UK
Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making
1 March 2010
In 2009, the English NHS began collecting patient-reported outcome measures (PROMs) for four elective procedures. Using a series of structured questions that ask patients about their…
Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries
1 November 2009
This study compares pricing and reimbursement (P&R) policy for 43 orphan medicinal products (OMPs) across seven EU Member States: France, Germany, Italy, The Netherlands, Spain, Sweden…
How Fair? Competition between Independent and NHS Providers to Supply Non-Emergency Hospital Care to NHS Patients in England
1 September 2009
Written while Labour Government policies still were in force, this Briefing clearly and thoroughly examines non-discretionary cost differences between public and independent providers that may have…
Compendium of Health Statistics
1 January 2009
The annual OHE Compendium of Health Statistics is the one-stop statistical information source on population and health trends in the UK, and the changing finances and…
Medical Research: What’s It Worth?
1 November 2008
Understanding the nature, extent and processes involved in the return on investment in medical research has been largely neglected as an area of serious scientific study.…
New Guidelines for Economic Evaluation in Germany and the United Kingdom: Are We Any Closer to Developing International Standards?
1 November 2008
Australia was the first, in 1993, to make economic evaluation an important component of its decisions about reimbursement of drugs. Since then, several jurisdictions have followed…
Sixty Years of the NHS: Changes in Demographics, Expenditure, Workforce and Family Services
1 September 2008
This series of articles celebrates the 60th anniversary of the UK National Health service (NHS). The series shows how certain areas associated with health have changed…
The Faces of Regulation: Profit and Price Regulation of the UK Pharmaceutical Industry after the 1998 Competition Act
1 May 2006
This Briefing discusses, inter alia, the role of the Office of Fair Trading (OFT) in competition cases affecting the pharmaceutical industry. It does so in the…
Health Systems Performance Assessment
1 April 2006
Annual lecture by Christopher Murray, who speaks in the UK about the work on health systems performance assessment (HSPA) at the World Health Organization. He gives…